Oasis Fertility announced on August 25 that private equity firm Kedaara Capital has invested in its business and acquired a minority stake in the company.
The fertility chain said the investment intends to advance Oasis' vision of being a research-driven, clinical excellence-oriented fertility platform by strengthening its organic expansion across India and neighbouring markets and accelerating inorganic partnerships.
This is Kedaara's second investment in the healthcare industry's single-speciality division.
Along with this $50 million deal, there is also a commitment by Kedaara Capital to deploy further capital for strategic acquisitions.
Oasis Fertility has expanded to a network of 26 clinics spread across 16 locations since 2009. The entity said its Oasis’ scientific and excellence-oriented culture has enabled it to bring pioneering treatments and procedures to the fertility market which is reflected in its high success rates.
Further, it is stated that Oasis enjoys a strong reputation for handling complex cases and delivering successful outcomes in patients with a history of unsuccessful IVF treatments.
The fertility chain also mentioned it runs a unique, accredited in-house training academy, Oasis School for Human Embryology and Reproductive Medicine (OSHERM), that has trained over 200 medical professionals and published over 60 research papers.
Oasis had also launched first-of-its-kind andrology (male infertility) practice, known as AndroLife.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
